-
DURECT Corporation Down Nearly 20% Pre-Market on FDA Rejection
Friday, June 24, 2011 - 7:24am | 34DURECT Corporation (NASDAQ: DRRX) is down nearly 20% pre-market after FDA rejected a drug that the company partially responsible for. The company is trading at $2.49 in pre-market.
-
A Peek Into The Market Before The Trading Starts
Friday, June 24, 2011 - 7:22am | 428Pre-open movers US stock futures are higher this morning, as investors are awaiting the third release of US Q1 gross domestic product and data on May durable-goods orders. Futures on the Dow Jones Industrial Average surged 20 points to 11,996.00 and futures on the S&P 500 stock index rose 1.80...
-
ViroPharma Announces Positive CHMP Opinion for Buccolam in the European Union
Friday, June 24, 2011 - 7:09am | 81ViroPharma Incorporated (Nasdaq: VPHM) earlier today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of a Pediatric Use Marketing Authorization for Buccolam, for treatment of prolonged, acute,...
-
Friday Stock Watchlist: 5 Technical Setups to Watch
Friday, June 24, 2011 - 6:15am | 1813( click to enlarge ) Good Morning, Traders. TEKELEC (NASDAQ:TKLC) looks ripe for an explosive move upwards. The stock had a bullish momentum on Thrusday, gaining more than 7% and closing near the highs of the session. Very strong. So, with the bulls pushing shares higher, I expect the stock...
-
Stocks to Watch for 6/24/11: Fresh 52 Week Highs and Lows
Friday, June 24, 2011 - 4:30am | 2005Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels. The following stocks hit new 52-week highs in Thursday's trading session: 1) Bristol-Myers Squibb (NYSE: BMY): Shares of Bristol-Myers Squibb hit a 52-week...
-
High Yield Big Pharmaceutical Stocks
Friday, June 24, 2011 - 1:19am | 436Between 1945 and 1964, seventy-six million American babies were born, making up what is now known as the Baby Boomers. The Boomers buy 77% of all prescription drugs and 61% of over-the-counter medications. Many income investors are looking for dividend stocks in the health care sector due to the...
-
Market Battles Back 06-23-2011
Thursday, June 23, 2011 - 7:00pm | 956Cusick's Corner As I mentioned yesterday and in today's Midday, Tech was really strong (look at the QQQs) and that leadership buoyed a weak market and by the afternoon, sectors like Consumer Discretionary, XLY, Housing, XHB, and even Finance, XLF, joined the advance. The table is now setting up...
-
FDA Accepts Endo Pharmaceuticals' Complete Response for New Formulation of OPANA ER
Thursday, June 23, 2011 - 4:46pm | 88Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it received notification from the U.S. Food and Drug Administration that Endo's complete response to the FDA's Jan. 7, 2011 Action Letter relating to Endo's new drug application for a new formulation of OPANA ER has been accepted. The new...
-
Two New RAFI Fundamental Pure Style ETFs From PowerShares
Thursday, June 23, 2011 - 3:59pm | 673Last week (6/16/11), PowerShares rebranded seven of the nine ETFs in its suite of “Dynamic” style box ETFs as “Fundamental Pure” style box ETFs. For some reason, the PowerShares Dynamic Large Cap Growth Portfolio (PWB) and PowerShares Dynamic Large Cap Value Portfolio (PWV) were excluded from this...
-
Critical Levels Broken 06-23-2011
Thursday, June 23, 2011 - 2:44pm | 1052Cusick's Corner Critical levels were broken in both equities and commodities and the Dollar currently is the trade. I did cover my short deltas this morning and am sitting flat but want to see if the Midday lows entice the Bid, seeing a little action in select names. In bond trading -- yields...
-
Teva Pharmaceutical Down Slightly As Supreme Court Says Generics Can't Be Sued
Thursday, June 23, 2011 - 1:02pm | 219Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA) shares are down slightly today, but off the lows of the session as the U.S. Supreme Court ruled that generic drug companies cannot be sued under state law over side effects. The Supreme Court said that the company, along with others such as Mylan...
-
Thursday's Mid-Day Options Volume Leaders
Thursday, June 23, 2011 - 12:26pm | 85Here are today's mid-day options volume leaders… 1. Apple Inc. (NASDAQ: AAPL) 186,328 contracts, 50.4% calls, 49.6% puts 2. Bank of America (NYSE: BAC) 149,728 contracts, 46.3% calls, 53.7% puts 3. Fifth Third Bancorp (NYSE: FITB) 68,387 contracts, 50.0% calls, 50.0% puts 4. Bristol Myers Squibb (...
-
J.P. Morgan Maintains Neutral on Bristol Myers Squibb
Thursday, June 23, 2011 - 9:44am | 138J.P. Morgan is out with its report today on Bristol Myers Squibb (NYSE: BMY), maintaining Neutral. In a note to clients, J.P. Morgan writes, "Bristol and Pfizer (NYSE: PFE) today released very positive top-line results of the key phase III ARISTOTLE trial comparing apixaban to warfarin in patients...
-
ViroPharma Shares Offer a Buying Opportunity at Current Levels, Piper Jaffray Reports
Thursday, June 23, 2011 - 8:49am | 105Piper Jaffray spent the day marketing with ViroPharma Inc. (NASDAQ: VPHM) management and “walked away with increased conviction that VPHM shares offer a buying opportunity at current levels regardless of the timing of expected generic competition for Vancocin.” “We see upside to Cinryze in the U.S...
-
Forest Labs and Watson Pharma to Open Near 52-Week Highs
Thursday, June 23, 2011 - 8:44am | 288Forest Laboratories (NYSE: FRX) and Watson Pharmaceuticals (NYSE: WPI) reached new 52-week highs of $40.52 and $66.00 per share, respectively, in Wednesday's trading session. Forest Labs saw an upgrade from Argus and Duncan-Williams upgraded its price target on the stock to $45 in the wake of...